Clinical Trials on Interferon

Total 19 results

University of Pittsburgh
Bill and Melinda Gates Foundation; MIMR-PHI Institute, Australia

Completed

Expression of IFN-epsilon in the Female Reproductive Tract (Epsilon)

Interferon Expression in the Female Reproductive Tract

United States
Vidara Therapeutics Research Ltd

Unknown

Determining the Effect of Actimmune (Interferon Gamma 1b)Dose Titration on Flu-Like Symptoms in Healthy Volunteers (FLS)

Adverse Effects in the Therapeutic Use of Interferon

United States
Henan Cancer Hospital

Recruiting

The Maintenance Treatment of "ITIVA" in AML Patients

Acute Myeloid Leukemia | Thalidomide | Maintenance Treatment | Minor Residue Disease | Interferon-α-1b | Interleukin-2 | Venentoclax | Azacitidine

China
Rigshospitalet, Denmark
Copenhagen Lupus and Vasculitis Clinic, Center for Rheumatology and Spine...

Active, not recruiting

Type 1 Interferon Induced Changes to Exercise Adaptations in Systemic Lupus Erythematosus Patients (LUPEX)

Systemic Lupus Erythematosus | Interferon Deficiency

Denmark
Armed Forces Capital Hospital, Republic of Korea

Completed

QuantiFERON Change During Anti-tuberculosis Medication

Tuberculosis | Interferon-gamma Release Assay

Korea, Republic of
Peking University People's Hospital

Withdrawn

Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation

Relapse | Prevention | Interferon-A-2B | Hematopietic Stem Cell Transplantation

China
Tongji Hospital

Unknown

Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients

COVID-19 | Recombinant Human Interferon α1β
Dermatologic Cooperative Oncology Group

Unknown

Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon

Therapy | Adjuvant | Stage III Malignant Melanoma | Interferon Alpha

Germany
Centre Hospitalier Universitaire, Amiens

Completed

Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study (COV-NI)

COVID-19 | INTERFERON | NEBULIZATION

France
University of Siena

Unknown

IGRA and Mantoux Response in Children With Suspected Latent or Active TB Infection (TBTubercolar)

Tuberculosis, Pulmonary | Interferon-gamma Release Tests | Tuberculin Test

Italy
Pontificia Universidad Catolica de Chile
Telethon Kids Institute

Completed

The Containing Coronavirus Disease 19 (COVID-19) Trial (ConCorD-19)

Covid19 | SARS-CoV Infection | Interferon

Chile
Junqi Niu
Chinese Academy of Sciences

Unknown

Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2) (sIFN-pred2)

Liver Diseases | Hepatitis C, Chronic | Interferon Deficiency

China
Emory University

Completed

Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C

Depression | Hepatitis C | Interferon-alpha Associated Side Effects
National Taiwan University Hospital

Completed

Surveillance and Follow-up for Latent Tuberculosis Infection and Risk of Developing Active Tuberculosis in Patients Receiving Long-term Dialysis

To Predict the Potential of Development of Active Tuberculosis in Those Receiving Long-term Dialysis by Using Interferon-gamma Release Assy

Taiwan
The First Hospital of Jilin University

Completed

The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients

Hepatitis B | Interferon
National Cancer Institute, Milan
Associazione Italiana per la Ricerca sul Cancro

Completed

Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis

Liver Cirrhosis | Hepatocellular Carcinoma | Hepatitis C Virus Infection | Hepatic Resection | Interferon Treatment

Italy
King Chulalongkorn Memorial Hospital

Completed

Treatment Outcome Between Mycobacterium Abscessus Infection in Chronic Lung Disease and Acquired Interferon-gamma Autoantibody Syndrome

Mycobacterium Abscessus Infection | Nontuberculous Mycobacterial Pulmonary Infection | Adult-Onset Immunodeficiency With Acquired Anti-Interferon-Gamma Autoantibodies

Thailand
Guangxi Medical University
Guilin Medical College; Second Affiliated Hospital of Guangzhou Medical University and other collaborators

Unknown

Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole Therapy (CSHHTVASIT)

Talaromyces in Human Immunodeficiency Virus Negative | To Compare Voriconazole and Amphotericin Sequential Itraconazole Therapy | To Dynamically Monitor the Anti-Interferon-γ Autoantibodies

China
Eli Lilly and Company

No longer available

Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes

Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE) | Juvenile Dermatomyositis (JDM) | Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset During Infancy (SAVI) | Aicardi-Goutières Syndrome (AGS)

United States, United Kingdom

Clinical Trials on Interferon

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations